2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92587°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Äڷγª ½Ã´ë, ´õ Å« Á¤ºÎ ¿ªÇÒ ¿ä±¸ (2021-04-03)
»ï¼ºÀüÀÚ, ±¹³» ÆÕ¸®½º °í°´ À§ÇÑ ÆÄ¿îµå¸® ¼Ö·ç¼Ç °ø°³ (2018-07-07)
SKÅÚ·¹ÄÞ, µðÁöÅÐ ¹Ìµð¾î·¾ ¡®ÀÎÅ©·Î½º¡¯ ÁöºÐÀμö (2019-04-12)
¾ÆÆ¼½ºÆ®ºò¸®±×¿¬ÇÕ, ¡®¾ÆÆ¼½ºÆ®ºò¸®±×¡¯ °³ÃÖ (2019-04-12)
ÀÇ·ù »ý»ê Ç÷§Æû ¡®¿À½½¡¯ (2020-12-18)
ÀΰøÁö´É DX Àü¹®±â¾÷ ÆÄ¿öÁ¨, ÄÚ½º´Ú ÀÔ¼º (2022-01-07)
Â÷·® ³» µðÁöÅÐ ÄÛÇÍ ºÐ¾ß ¾÷¹« Çù·Â (2022-03-25)
K-µðÁöÅаúÁ¤ ½ÅÀÔ»ý ¸ðÁý (2022-03-25)
Recover Accelerates Growth With $100 Million Minority Equity... (2022-06-10)
Â÷¼¼´ë ¼ºÀå »ê¾÷, UÇコ ºÐ¾ß ƯÇãÃâ¿ø Áõ°¡ (2014-02-20)
¼Ò»ó°øÀÎ 34% ¡°»õÇØ ü°¨°æ±â ÀÛ³â°ú ºñ½Á¡± (2020-01-16)
¹é·Éµµ¿¡¼­ ¹Ì±â·Ï ½Ä¹° ¡®¾ç¹ÚÇÏ¡¯ ¹ß°ß (2013-02-19)
Çö´ë·ÎÅÛ, źÀÚ´Ï¾Æ Àüµ¿Â÷¡¤Àü±â±â°üÂ÷ ¼öÁÖ (2021-07-08)
Visa Introduces Crypto Advisory Services to Help Partners Na... (2021-12-09)
¼­¿ï½Ã, Ãß¼® 5´ë Á¾ÇÕ´ëÃ¥ ½ÃÇà (2018-09-12)
¼­ºñ½º, ±×¸¸ÇϰڽÀ´Ï´Ù (2019-02-13)
½Ö¿ëÂ÷, Åä·¹½º Ãâ°í È®´ë À§ÇØ ÃÑ·Â »ý»ê (2022-07-28)
Çö´ëÀÚµ¿Â÷, ¡®2023 º£´º¡¯ Ãâ½Ã (2022-10-13)
ä¿ï¿÷½º, KCA ¹æ¼Û Á¦ÀÛ Áö¿ø ´ë»ó ¼±Á¤ (2020-08-05)
¹è¿ì À̹ÎÈ£, ÇÁ·Î¹ÌÁî ÅëÇØ ±âºÎ±Ý Àü´Þ (2021-01-06)
¡®ÅÚ·ç¶óÀ̵塯 ÃÖÃÊ ½ÇÂ÷ °ø°³ (2019-01-15)
Çö´ëÂ÷ Ãʰí¼Ó ÃæÀü ºê·£µå ¡®E–pit¡¯ (2021-03-24)
¾Ó°ñ¶ó¿¡ 22MW ±Ô¸ð ž籤 ¸ðµâ °ø±Þ (2023-06-01)
¾ÆÀ̵¥¹Ì¾Æ, Àεµ ź¼Ò ÇÁ·ÎÁ§Æ®¿¡ ÅõÀÚ (2021-06-09)
¿¡ÀÌÆ¼Áî ¡®Answer¡¯, ÁÖ°£ ÅõÇ¥ ÃÖ°íÀÇ °î 1À§ (2020-02-04)
       [ÀÌÀü][1]....[2975][2976][2977][2978][2979][2980][2981][2982][2983]...[3704][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..